Cencora (COR) to Release Quarterly Earnings on Wednesday

04 May 2026, 08:34 by Teresa Graham · The Cerbat Gem

Cencora (NYSE:COR – Get Free Report) is projected to announce its Q2 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of $4.81 per share and revenue of $81.0878 billion for the quarter. Investors can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:30 AM ET.

Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. The company had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.Cencora’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the business earned $3.73 earnings per share. On average, analysts expect Cencora to post $18 EPS for the current fiscal year and $20 EPS for the next fiscal year.

Cencora Stock Up 0.1%

Shares of COR stock opened at $304.18 on Monday. The stock has a 50 day moving average of $333.36 and a 200 day moving average of $343.31. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a market cap of $59.17 billion, a P/E ratio of 36.56, a P/E/G ratio of 1.42 and a beta of 0.64. Cencora has a twelve month low of $271.00 and a twelve month high of $377.54.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a $0.60 dividend. The ex-dividend date was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s payout ratio is 28.85%.

Institutional Trading of Cencora

Several large investors have recently made changes to their positions in COR. United Bank increased its position in shares of Cencora by 4.5% during the second quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after purchasing an additional 305 shares in the last quarter. Nebula Research & Development LLC purchased a new stake in shares of Cencora during the second quarter worth approximately $595,000. Treasurer of the State of North Carolina increased its position in shares of Cencora by 7.9% during the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after purchasing an additional 6,244 shares in the last quarter. Diversify Advisory Services LLC increased its position in shares of Cencora by 94.1% during the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after purchasing an additional 1,253 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in shares of Cencora by 26.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after purchasing an additional 15,154 shares in the last quarter. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on COR shares. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. William Blair started coverage on Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating for the company. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. JPMorgan Chase & Co. boosted their price objective on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Finally, Robert W. Baird set a $415.00 price objective on Cencora in a research report on Tuesday, January 13th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cencora currently has an average rating of “Moderate Buy” and a consensus price target of $398.17.

Read Our Latest Analysis on COR

Cencora Company Profile

(Get Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.